Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety
Albumin solutions derived from human plasma have demonstrated clinical benefits as intravenous fluid therapy in clinical settings such as liver disease, sepsis, intensive care, and surgery. For all plasma-derived medicinal products, there is a potential risk from pathogens, including relevant blood-...
Main Authors: | Toby Simon, Philipp Schumann, Michael Bieri, Kathrin Schirner, Eleonora Widmer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biosafety and Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590053622001793 |
Similar Items
-
RESUSCITATION OF CONTROLLED HEMORRHAGIC SHOCK IN HYPERTENSIVE AND NORMOTENSIVE RAT MODELS: THE EFFECTS OF HYPERTONIC-HYPERONCOTIC SOLUTIONS
by: M NEEMATBAKHSH, et al.
Published: (2001-09-01) -
Use of Hyperoncotic Human Albumin Solution in Severe Traumatic Brain Injury Revisited—A Narrative Review and Meta-Analysis
by: Christian J. Wiedermann
Published: (2022-05-01) -
Serum Ischemia-Modified Albumin Concentration and Ischemia-Modified Albumin/Albumin Ratio in Hyperemesis Gravidarum
by: Fatma Beyazıt, et al.
Published: (2018-12-01) -
Microparticle Deposition on Human Serum Albumin Layers: Unraveling Anomalous Adsorption Mechanism
by: Małgorzata Nattich-Rak, et al.
Published: (2020-11-01) -
The Value of Fibrinogen/Albumin Ratio on Prognosis of COVID-19 Patients
by: Dilcan Kotan, et al.
Published: (2022-08-01)